BridgeMD
New treatment option for Tuberculosis
Official title Increased Tuberculosis Case Detection - DiOpTB
ClinicalTrials.gov ID: NCT06437184
What this study is testing
- What it's testing
- As estimated by the WHO 10.6 million new Tuberculosis (TB) cases were identified in 2022- while more than three million went undetected and untreated. The low detection rate illustrates the failure to recognise and diagnose TB in the current cascade of healthcare and is a major obstacle to effective TB control programs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 120
You may be able to join if
- ≥15 years old
- presumed TB with cough, sputum production, and/or weight loss of any duration
You likely can't join if
- TB treatment within the past year.
- Cerebral disturbances impairing the ability to give informed consent or follow the treatment regime.
The study team makes the final eligibility decision.
Where it's taking place
- Gonder, Ethiopia
- Bissau, Guinea-Bissau
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 120 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gonder, Ethiopia; Bissau, Guinea-Bissau. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.